Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 14;24(1):109.
doi: 10.1186/s13075-022-02796-9.

Increased frequency of IgD-CD27hiCD38hi B cells and its association with the renal involvement in ANCA-associated vasculitis

Affiliations

Increased frequency of IgD-CD27hiCD38hi B cells and its association with the renal involvement in ANCA-associated vasculitis

Chen Wang et al. Arthritis Res Ther. .

Abstract

Background: B cells have been highlighted in the pathogenesis of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) by the identification of activated B cells in granulomatous lesions and the efficacy of B cell depletion in treatment of AAV patients in the current study; we aimed to investigate the frequency of a specific B cell subset, IgD-CD27hiCD38hi B cells in AAV patients, and its association with the disease severity of AAV.

Methods: Blood samples of patients with AAV in active stage and in remission were collected. The frequency of IgD-CD27hiCD38hi B cells was detected by flow cytometry, and its correlation with clinicopathological parameters was analyzed.

Results: Our results showed a significant increase of circulating IgD-CD27hiCD38hi B cells in AAV patients in active stage compared with patients in remission and healthy donors, and the frequency of IgD-CD27hiCD38hi B cells correlated with the severity of renal involvement, including serum creatinine, estimated glomerular filtration rate, and percentages of total crescents in renal biopsies.

Conclusions: The results indicated that IgD-CD27hiCD38hi B cells could reflect disease severity of renal involvement in AAV.

Keywords: Antineutrophil cytoplasmic antibody; B cells; Renal involvement; Vasculitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
A representative gating example of sequential blood sample from an AAV patient. A The distribution of IgD-CD27hiCD38hi B cells in the patient in active stage. B the distribution of IgD-CD27hiCD38hi B cells in the patient in remission
Fig. 2
Fig. 2
Increased frequency of IgD-CD27hiCD38hi B cells in patients with active AAV. A The frequency of IgD-CD27hiCD38hi B cells among CD19+ B cells was significantly increased in the AAV patients in active stage than those in both AAV patients in remission and healthy donors. B The frequency of IgD-CD27hiCD38hi B cells among CD45+ leukocytes was significantly increased in the AAV patients in active stage than those in both AAV patients in remission and healthy donors. C The frequency of IgD-CD27hiCD38hi B cells among CD19+ B cells was significantly increased in active stage than that in remission in 8 AAV patients with sequential blood samples of both active stage and remission. D The frequency of IgD-CD27hiCD38hi B cells among CD45+ leukocytes was significantly increased in active stage than that in remission in 8 AAV patients with sequential blood samples of both active stage and remission
Fig. 3
Fig. 3
Association between frequency of IgD-CD27hiCD38hi B cells and severity of renal involvement in patients with active AAV. A The frequency of IgD-CD27hiCD38hi B cells correlated with Scr. B The frequency of IgD-CD27hiCD38hi B cells correlated with eGFR. C The percentages of total crescents in renal biopsies were significantly higher in patients with ≥7.29% IgD-CD27hiCD38hi B cells frequency than patients with <7.29% IgD-CD27hiCD38hi B cells frequency

Similar articles

Cited by

References

    1. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1–11. doi: 10.1002/art.37715. - DOI - PubMed
    1. Falk RJ, Jennette JC. ANCA small-vessel vasculitis. J Am Soc Nephrol. 1997;8(2):314–322. doi: 10.1681/ASN.V82314. - DOI - PubMed
    1. Shi L. Anti-neutrophil cytoplasmic antibody-associated vasculitis: prevalence, treatment, and outcomes. Rheumatol Int. 2017;37(11):1779–1788. doi: 10.1007/s00296-017-3818-y. - DOI - PubMed
    1. Little MA, Smyth CL, Yadav R, Ambrose L, Cook HT, Nourshargh S, Pusey CD. Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood. 2005;106(6):2050–2058. doi: 10.1182/blood-2005-03-0921. - DOI - PubMed
    1. Kettritz R. How anti-neutrophil cytoplasmic autoantibodies activate neutrophils. Clin Exp Immunol. 2012;169(3):220–228. doi: 10.1111/j.1365-2249.2012.04615.x. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances